NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Global advocacy nonprofit Made of Millions today debuted a new platform under the same name that includes an expanded library of mental

NEW YORK, Feb. 27, 2020 /PRNewswire/ -- SWORD Health (SWORD), a tech-enabled provider of musculoskeletal care, today announced the addition of $9 million to their Series A investment, bringing their total Series A investment to $17 million. The addition was led by Khosla Ventures, with participation from Fo

TEL AVIV, Israel, Feb. 27, 2020 /PRNewswire/ -- The Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, one of the

FORT WAYNE, Ind., Feb. 27, 2020 /PRNewswire/ -- Starring World Champion gymnast Aly Raisman, a new video from Master Spas shares the message of achieving balance through exercise and self-care.

DALLAS, Feb. 27, 2020 /PRNewswire/ -- The American Heart Association states

FRESNO, Calif., Feb. 27, 2020 /PRNewswire/ -- Once just a snack, pistachios possess extracts that have been shown to stop the growth of Staphylococcus aureus, MRSA, Listeria and Herpes simplex virus (HSV-1) —important findings amid growing antibiotics resistance and the increased need for new medical treatments. In a study published this month in

HIGHLANDS RANCH, Colo., Feb. 27, 2020 /PRNewswire/ -- Destination Pet today announced that Bryan Mooney will join the company as Senior Vice President. Mooney will assume the role effective immediately, reporting to Shane Kelly, Global CEO. As part of his role, Mooney will lead the integration of new assets in

SALT LAKE CITY, Feb. 27, 2020 /PRNewswire/ -- In an effort to minimize the use of narcotics after and during surgery, Intermountain Healthcare is the first health system in Utah to establish an opioid-free surgery program for patients seeking alternative pain control methods.

PETAH TIKVA, Israel, Feb. 27, 2020 /PRNewswire/ -- PolyPid Ltd., a Phase 3 clinical-stage  biopharmaceutical company focused on developing targeted, locally administered and prolonged-release therapeutics using its proprietary PLEX technology, today announced

FARMVILLE N.C., Feb. 27, 2020 /PRNewswire/ -- Specialty pharmaceutical company CMP Pharma, Inc. announced today that its Potassium Phosphates Injection, the first ever FDA Approved Potassium Phosphates Injection, was approved on September 19, 2019. This will provide Health Care Providers, for the first time, an FDA approved potassium ph